Explore selected publications, evidence types, key findings, and registered studies with direct links to each primary record. This curated library is not a complete archive of the thousands of studies across the wider scientific literature.
5 publications
Showing records relevant to SS-31.
Key finding
The study reports that mean BTHS-SA Total Fatigue scores were below baseline (improved) at all OLE time points.
Genetics in medicine : official journal of the American College of Medical Genetics 2024
Research relevant to SS-31. Relevant to SS-31
Key finding
The study reports that at baseline, the mean distance walked on the 6MWT was 336.7 ± 81.2 meters, the mean score for total fatigue on the PMMSA was 10.6 ± 2.5, and the mean T score for the Neuro-QoL Fatigue Short-Form was 54.7 ± 7.5.
Neurology 2023
Research relevant to SS-31. Relevant to SS-31
Key finding
The study reports that lPS-induced memory impairment can be attenuated by the mitochondrion-targeted antioxidant elamipretide.
Journal of neuroinflammation 2019
Direct SS-31 evidence. Relevant to SS-31
Key finding
The study reports that further research may expand its application to other diseases involving mitochondrial dysfunction as well as investigate long-term efficacy and safety of the drug.
International journal of molecular sciences 2025
Research relevant to SS-31. Relevant to SS-31
This library supports source-led professional evaluation. Product-specific clinical and regulatory guidance provides the framework for interpreting the records in context.
Browse all products